Existing drug delivery methods have not led to a significant increase in survival for patients
with malignant primary brain tumors. While the combination of conventional therapies …

The chromatin remodeler SMARCA4/BRG1 is a key epigenetic regulator with diverse roles
in coordinating the molecular programs that underlie brain tumour development. BRG1 …

Simple Summary Pediatric brain tumors represent a formidable challenge in the field of
oncology. Pediatric brain tumors are sub-classified into several molecular sub-types, where …

Background Accumulating evidence suggests a positive association between exposure to
non-agricultural pesticides and childhood brain tumors (CBT). Objective (1) To conduct a …

Simple Summary After leukemias, brain tumors are the most common cancers in children,
and early, accurate diagnosis is critical to improve patient outcomes. Beyond the …

Although tremendous progress has been made in treating childhood cancer, it is still one of
the leading causes of death in children worldwide. Because cancer symptoms overlap with …

The limited efficacy of traditional cancer treatments, including chemotherapy, radiotherapy,
and surgery, emphasize the significance of employing innovative methods. CAR (Chimeric …

After leukemia, tumors of the brain and spine are the second most common form of cancer in
children. Despite advances in treatment, brain tumors remain a leading cause of death in …

Brain tumors are the most common solid tumors in childhood. There is the need for
biomarkers of residual disease, therapy response and recurrence. Cerebrospinal fluid (CSF) …

Congenital brain tumors are rare accounting for 0.5%–1.9% of all pediatric brain tumors.
While different criteria have been used to classify a tumor as congenital, those diagnosed …